UBS Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
UBS Group's DXCM Position: Q3 2026 in Review
UBS Group reduced its DexCom (DXCM) stake by 59% in Q3 2026, selling an estimated $296M and leaving 2,512,257 shares worth $217M. The position accounts for 0.03% of the portfolio, ranked #615.
UBS Group first reported a position in DXCM in Q4 2014 and has held it in 48 quarters since. The position peaked at $409M in Q2 2026. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- UBS Group held 2,512,257 shares of DexCom worth $217M as of Q3 2026.
- UBS Group sold 3,553,522 DexCom shares in Q3 2026, an estimated $296M.
- DexCom made up 0.03% of UBS Group's portfolio in Q3 2026, its #615 holding.
- UBS Group first reported a position in DexCom in Q4 2014 and has held it in 48 quarters since.
- UBS Group's DexCom position peaked at $409M in Q2 2026.
- 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.